Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s21, 2021. DOI: 10.25251/skin.5.supp.21. Disponível em: https://skin.dermsquared.com/skin/article/view/1174. Acesso em: 1 may. 2026.